The show must go on. Reply to "Distinct functions of S-ketamine and R-ketamine in mediating biobehavioral processes of drug dependency: comments on Bonaventura et al" by Insop Shim.

Bonaventura, Jordi; Lam, Sherry; Carlton, Meghan; Boehm, Matthew; Gomez, Juan L; Solís, Oscar; Sánchez-Soto, Marta; Morris, Patrick J; Fredriksson, Ida; Thomas, Craig J; Sibley, David R; Shaham, Yavin; Zarate, Carlos A; Michaelides, Michael

Bonaventura, Jordi; Lam, Sherry; Carlton, Meghan; Boehm, Matthew; Gomez, Juan L; Solís, Oscar; Sánchez-Soto, Marta; Morris, Patrick J; Fredriksson, Ida; Thomas, Craig J; Sibley, David R; Shaham, Yavin; Zarate, Carlos A; Michaelides, Michael.

Afiliación

Bonaventura J; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907, Catalonia, Spain. jbonaventura@ub.edu.
Lam S; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 212242, USA.
Carlton M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 212242, USA.
Boehm M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 212242, USA.
Gomez JL; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 212242, USA.
Solís O; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 212242, USA.
Sánchez-Soto M; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, MD, 20892, USA.
Morris PJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, Rockville, MD, 20850, USA.
Fredriksson I; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 212245, USA.
Thomas CJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, Rockville, MD, 20850, USA.
Sibley DR; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, MD, 20892, USA.
Shaham Y; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 212245, USA.
Zarate CA; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, Intramural Research Program, Bethesda, MD, 20892, USA.
Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 212242, USA. mike.michaelides@nih.gov.

Mol Psychiatry ; 2022 Jun 22.

Article en En | MEDLINE | ID: mdl-35732692

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google